BDX FY 2023 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

FY 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$19.4B+2.7% YoY

Gross Profit

$8.2B42.2% margin

Operating Income

$2.1B10.9% margin

Net Income

$1.5B7.7% margin

EPS (Diluted)

$4.94

Cash Flow

Operating Cash Flow

$3.0B

Free Cash Flow

$2.1B

Stock-Based Comp.

$259M

Balance Sheet

Total Assets

$52.8B

Total Liabilities

$27.0B

Stockholders' Equity

$25.8B

Cash & Equivalents

$1.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19.4B	$18.9B	+2.7%
Gross Profit	$8.2B	$8.5B	-3.6%
Operating Income	$2.1B	$2.3B	-7.5%
Net Income	$1.5B	$1.8B	-16.6%